Your browser doesn't support javascript.
loading
Rationale and study design of the GOREISAN for heart failure (GOREISAN-HF) trial: A randomized clinical trial.
Yaku, Hidenori; Kato, Takao; Morimoto, Takeshi; Kaneda, Kazuhisa; Nishikawa, Ryusuke; Kitai, Takeshi; Inuzuka, Yasutaka; Tamaki, Yodo; Yamazaki, Taketoshi; Kitamura, Jun; Ezaki, Hirotaka; Nagao, Kazuya; Yamamoto, Hiromi; Isotani, Akihiro; Takeshi, Arita; Izumi, Chisato; Sato, Yukihito; Nakagawa, Yoshihisa; Matoba, Satoaki; Sakata, Yasushi; Kuwahara, Koichiro; Kimura, Takeshi.
Affiliation
  • Yaku H; Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan; Department of Cardiology, Northwestern University Feinberg School of Medicine, Chicago, IL. Electronic address: yakuh@kuhp.kyoto-u.ac.jp.
  • Kato T; Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Morimoto T; Clinical Epidemiology, Hyogo College of Medicine, Nishinomiya, Japan.
  • Kaneda K; Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Nishikawa R; Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Kitai T; Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
  • Inuzuka Y; Department of Cardiovascular Medicine, Shiga General Hospital, Moriyama, Japan.
  • Tamaki Y; Division of Cardiology, Tenri Hospital, Nara, Japan.
  • Yamazaki T; Department of Internal Medicine, Rakuwakai Otowa Rehabilitation Hospital, Kyoto, Japan.
  • Kitamura J; Department of Internal Medicine, Kobe Kaisei Hospital, Kobe, Japan.
  • Ezaki H; Department of Cardiology, Tokorozawa Heart Center, Tokorozawa, Japan.
  • Nagao K; Department of Cardiology, Osaka Red Cross Hospital, Osaka, Japan.
  • Yamamoto H; Department of Cardiology, Kurashiki Central Hospital, Kurashiki, Japan.
  • Isotani A; Department of Cardiology, Kokura Memorial Hospital, Kitakyushu, Japan.
  • Takeshi A; Division of Cardiovascular Medicine Heart & Neuro-Vascular Center, Fukuoka Wajiro, Fukuoka, Japan.
  • Izumi C; Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
  • Sato Y; Department of Cardiology, Hyogo Prefectural Amagasaki General Medical Center, Amagasaki, Japan.
  • Nakagawa Y; Department of Cardiovascular Medicine, Shiga University of Medical Science, Otsu, Japan.
  • Matoba S; Department of Cardiovascular Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Sakata Y; Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Japan.
  • Kuwahara K; Department of Cardiovascular Medicine, Shinshu University Graduate School of Medicine, Nagano, Japan.
  • Kimura T; Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Am Heart J ; 260: 18-25, 2023 06.
Article in En | MEDLINE | ID: mdl-36841318
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sodium Potassium Chloride Symporter Inhibitors / Heart Failure Type of study: Clinical_trials Aspects: Patient_preference Limits: Humans Language: En Journal: Am Heart J Year: 2023 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sodium Potassium Chloride Symporter Inhibitors / Heart Failure Type of study: Clinical_trials Aspects: Patient_preference Limits: Humans Language: En Journal: Am Heart J Year: 2023 Document type: Article Country of publication: